About this trial
The goal of this clinical trial is to investigate the effect of a mobile application intervention on postoperative lung rehabilitation. The main purposes of this study are:
1. To understand the effectiveness of the pulmonary rehabilitation mobile application in improving lung function. 2. To assess the feasibility of the pulmonary rehabilitation mobile application in post-surgery rehabilitation care.
Researchers will compare the intervention group (using the pulmonary rehabilitation mobile application) to the usual care group to determine if the mobile application is effective in lung surgery rehabilitation.
Participants will join the study immediately after providing informed consent and will continue for up to 7 weeks post-surgery. Participants will be randomly allocated to either the intervention group or the control group. Both groups will receive regular pulmonary rehabilitation during their hospital stay (1 day before surgery and 2 to 3 days after surgery). Researchers will guide participants in the intervention group to use the mobile application for pulmonary rehabilitation exercises throughout the study period. Participants in the usual care group will receive health education and an exercise guide before discharge. Participants will undergo three study assessments: at baseline (within 1 week after enrollment), post-surgery (week 5), and at follow-up (week 8).
Eligibility criteria
Qualifiers
age over 20 years
primary diagnosis of lung cancer at any stage and type
referral to lung cancer resection by thoracotomy or videothoracoscopy
ability to understand and consent to the trial procedures
Disqualifiers
included adjuvant treatments (chemotherapy or radiotherapy)
previous history of thoracic surgery
neurological and/or musculoskeletal comorbidities
visual or hearing impairment
Trial design
Treatments tested in this trial
- RehabLung mobile application
- Lung cancer postoperative standard care
- Healthcare interactive Web Platform